END-AF 1
Clinical randomised Phase II trial of AP31969 versus Placebo for Rhythm control of atrial fibrillation
- Stage
- inclusie
- Medicine
- AP31969
- Population
- Ritme
- Phase
- II
- First Patient In
- 24 November 2025
- Last Patient In
- 31 December 2026
- Last Patient Last Visit
- 1 May 2027
Inclusion period, 234 days remaining
Study Director
dr. R.G. Tieleman
Cardioloog
Office Contact
